ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,291.34
0.15%
Dow Jones
38,711.29
0.36%
US Dollar vs MXN
17.6877
-0.72%
Brent Oil
77.765
0.85%
Bitcoin
70,949.30
0.46%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Pharmaceutical Prod Dev (MM) (PPDI)

  7. Pharmaceutical Prod Dev (MM) (PPDI) Noticias

PPDI

Pharmaceutical Product Developme (PPDI)

Pharmaceutical Prod Dev (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PPDI
FechaHoraFuenteTítuloSímboloCompañía
07/12/202108:00Business WirePPD Named to ‘Best Workplaces in Greater China’ for Second Consecutive YearNASDAQ:PPDIPharmaceutical Prod Dev (MM)
02/12/202108:00Business WirePPD Named ‘Best Vaccine CRO of the Year’ in Asia-PacificNASDAQ:PPDIPharmaceutical Prod Dev (MM)
22/11/202108:00Business WirePPD Wins Multiple Awards at Clinical Researcher of the Year CompetitionNASDAQ:PPDIPharmaceutical Prod Dev (MM)
27/10/202115:10Business WirePPD Reports Third Quarter and Year-To-Date 2021 ResultsNASDAQ:PPDIPharmaceutical Prod Dev (MM)
19/10/202108:00Business WirePPD Named Clinical Research Company of the Year for Second Consecutive YearNASDAQ:PPDIPharmaceutical Prod Dev (MM)
18/10/202115:05Business WirePPD Announces Third Quarter 2021 Earnings Conference CallNASDAQ:PPDIPharmaceutical Prod Dev (MM)
06/10/202108:00Business WireSociety for Clinical Research Sites Names PPD Winner of Prestigious Eagle AwardNASDAQ:PPDIPharmaceutical Prod Dev (MM)
21/09/202108:00Business WirePPD Earns Gold Award for Excellence in Employee Learning and DevelopmentNASDAQ:PPDIPharmaceutical Prod Dev (MM)
01/09/202108:00Business WirePPD Receives Award Recognizing Employee Talent DevelopmentNASDAQ:PPDIPharmaceutical Prod Dev (MM)
28/07/202115:11Business WirePPD Reports Second Quarter and Year-To-Date 2021 ResultsNASDAQ:PPDIPharmaceutical Prod Dev (MM)
20/07/202108:00Business WirePPD Recognized as a Best Place to Work in AsiaNASDAQ:PPDIPharmaceutical Prod Dev (MM)
12/07/202115:10Business WirePPD Announces Second Quarter 2021 Earnings Conference CallNASDAQ:PPDIPharmaceutical Prod Dev (MM)
27/05/202108:00Business WirePPD Named ‘Most Innovative CRO’ by Triangle Business JournalNASDAQ:PPDIPharmaceutical Prod Dev (MM)
24/05/202108:00Business WirePPD Opens Multipurpose Clinical Research Laboratory in Suzhou, ChinaNASDAQ:PPDIPharmaceutical Prod Dev (MM)
20/05/202120:00Business WirePPD百时益位于苏州的多功能临床研究实验室正式投入运营NASDAQ:PPDIPharmaceutical Prod Dev (MM)
20/05/202120:00Business WirePPD百時益位於蘇州的多功能臨床研究實驗室正式投入運營NASDAQ:PPDIPharmaceutical Prod Dev (MM)
20/05/202108:00Business WireCRO Leadership Awards Recognize PPD for Excellence for 10th Consecutive YearNASDAQ:PPDIPharmaceutical Prod Dev (MM)
06/05/202107:30Business WirePPD Named “Best CRO” at Vaccine Industry Excellence AwardsNASDAQ:PPDIPharmaceutical Prod Dev (MM)
28/04/202108:00Business WirePPD to Expand GMP Lab in Ireland to Enhance Biopharmaceutical Testing CapabilitiesNASDAQ:PPDIPharmaceutical Prod Dev (MM)
27/04/202115:13Business WirePPD Reports First Quarter 2021 ResultsNASDAQ:PPDIPharmaceutical Prod Dev (MM)
27/04/202108:00Business WirePPD and Science 37® Strengthen Collaboration to Advance Decentralized Clinical Trials and Accelerate DevelopmentNASDAQ:PPDIPharmaceutical Prod Dev (MM)
07/04/202108:00Business WirePPD Announces First Quarter 2021 Earnings Conference CallNASDAQ:PPDIPharmaceutical Prod Dev (MM)
24/03/202108:00Business WirePPD and Clinical Ink Collaborate on Innovative Process for Lupus Assessment and Near Real-Time Access to Endpoint DataNASDAQ:PPDIPharmaceutical Prod Dev (MM)
17/03/202108:27Business Wire PPD Named a Leader in Digital Clinical Trial Solutions by ISGNASDAQ:PPDIPharmaceutical Prod Dev (MM)
26/02/202109:00Business WirePPD Lights Up Headquarters Downtown for 2021 Rare Disease DayNASDAQ:PPDIPharmaceutical Prod Dev (MM)
24/02/202106:00Business WirePPD to Present at Barclays Global Healthcare ConferenceNASDAQ:PPDIPharmaceutical Prod Dev (MM)
23/02/202115:05Business WirePPD Reports Fourth Quarter and Full Year 2020 ResultsNASDAQ:PPDIPharmaceutical Prod Dev (MM)
18/02/202108:00Business WirePPD Awarded US Army Study to Help Develop Post-Traumatic Stress Disorder DrugsNASDAQ:PPDIPharmaceutical Prod Dev (MM)
17/02/202109:00Business WirePPD Honored for Employee Development Programs that Deliver Results for CustomersNASDAQ:PPDIPharmaceutical Prod Dev (MM)
03/02/202116:10Business WirePPD Announces Fourth Quarter and Full-Year 2020 Earnings Conference CallNASDAQ:PPDIPharmaceutical Prod Dev (MM)
 Showing the most relevant articles for your search:NASDAQ:PPDI

Su Consulta Reciente

NASDAQ
PTWOU
Pono Capital Two
UNSW
ICBETH
ICHIBA
EU
FGIND
EN Top 30 France Germany...
NASDAQI
OMXS30DVP
OMX Stockholm Dividend P...
BIT
P1YKR4
NLBNPIT1YKR4 20991231 20...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados